Jung Mogg Kim Selected Research

Clostridium difficile tcdA protein

4/2014	Mitogen-activated protein kinase/IκB kinase/NF-κB-dependent and AP-1-independent CX3CL1 expression in intestinal epithelial cells stimulated with Clostridium difficile toxin A.
2/2009	Clostridium difficile toxin A promotes dendritic cell maturation and chemokine CXCL2 expression through p38, IKK, and the NF-kappaB signaling pathway.
12/2007	Effects of transcription factor activator protein-1 on interleukin-8 expression and enteritis in response to Clostridium difficile toxin A.
1/2002	Differential expression and polarized secretion of CXC and CC chemokines by human intestinal epithelial cancer cell lines in response to Clostridium difficile toxin A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jung Mogg Kim Research Topics

Disease

25	Infections 01/2022 - 04/2002
16	Inflammation (Inflammations) 10/2021 - 04/2002
16	Colitis 07/2020 - 09/2005
10	Neoplasms (Cancer) 10/2016 - 01/2002
10	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2014 - 12/2006
7	Stomach Neoplasms (Stomach Cancer) 05/2015 - 04/2007
6	Carcinogenesis 03/2014 - 04/2004
4	Colonic Neoplasms (Colon Cancer) 11/2012 - 02/2008
4	Arthritis (Polyarthritis) 04/2009 - 03/2005
3	Colitis-Associated Neoplasms 03/2014 - 08/2008
3	Colorectal Neoplasms (Colorectal Cancer) 11/2012 - 02/2007
3	Peptic Ulcer (Peptic Ulcers) 12/2011 - 09/2003
2	Severe Fever with Thrombocytopenia Syndrome 01/2021 - 01/2021
2	Bacterial Infections (Bacterial Infection) 01/2020 - 04/2013
2	Lymphoma (Lymphomas) 06/2013 - 08/2007
2	Reinfection 04/2013 - 05/2006
2	Gastritis 01/2013 - 12/2011
2	Duodenal Ulcer (Curling's Ulcer) 12/2011 - 09/2005
2	Stomach Ulcer (Gastric Ulcer) 12/2011 - 05/2004
2	Enteritis 12/2007 - 09/2005
2	Coinfection 07/2006 - 05/2006
1	Stomach Diseases 01/2022
1	Leukopenia 01/2021
1	Dyspnea (Shortness of Breath) 01/2021
1	Fever (Fevers) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Disease Progression 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 10/2017
1	Clostridium Infections 12/2014
1	Metaplasia 04/2013
1	Atrophic Gastritis 04/2013
1	Obesity 07/2012

Drug/Important Bio-Agent (IBA)

9	NF-kappa B (NF-kB)IBA 07/2010 - 12/2003
8	Dextran SulfateIBA 03/2014 - 02/2007
8	Proteins (Proteins, Gene)FDA Link 01/2014 - 04/2004
7	Enterotoxins (Enterotoxin)IBA 07/2020 - 09/2005
5	Interleukin-8 (Interleukin 8)IBA 01/2014 - 04/2002
4	Interleukin-10 (Interleukin 10)IBA 01/2021 - 02/2007
4	Clostridium difficile tcdA proteinIBA 04/2014 - 01/2002
4	AzoxymethaneIBA 03/2014 - 02/2008
4	pregna-4,17-diene-3,16-dione (guggulsterone)IBA 06/2013 - 12/2006
3	Clarithromycin (Biaxin)FDA LinkGeneric 01/2022 - 09/2003
3	Moxifloxacin (Avelox)FDA Link 12/2015 - 02/2005
3	InterleukinsIBA 12/2014 - 12/2007
3	Phytosterols (Plant Sterols)IBA 01/2013 - 12/2006
3	DNA (Deoxyribonucleic Acid)IBA 11/2012 - 02/2003
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2011 - 05/2006
3	CytokinesIBA 12/2011 - 01/2004
3	Metronidazole (Metric)FDA LinkGeneric 02/2006 - 09/2003
2	Amoxicillin (Wymox)FDA LinkGeneric 01/2022 - 09/2003
2	EnzymesIBA 01/2021 - 02/2003
2	Neutralizing AntibodiesIBA 01/2021 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2020 - 08/2004
2	Heme Oxygenase-1IBA 01/2020 - 01/2016
2	Cadherins (E-Cadherin)IBA 11/2019 - 05/2015
2	Messenger RNA (mRNA)IBA 05/2015 - 09/2013
2	AutoantibodiesIBA 01/2014 - 04/2009
2	Therapeutic UsesIBA 06/2013 - 02/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2011 - 04/2006
2	Simvastatin (Zocor)FDA LinkGeneric 08/2008 - 02/2007
2	Oxidoreductases (Dehydrogenase)IBA 08/2008 - 02/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2008 - 05/2004
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2008 - 02/2007
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2007 - 09/2005
2	SB 203580IBA 12/2007 - 09/2005
2	BismuthIBA 05/2006 - 09/2003
2	Tetracycline (Achromycin)FDA LinkGeneric 02/2006 - 09/2003
2	AntigensIBA 03/2005 - 01/2003
1	AcidsIBA 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022
1	PotassiumIBA 01/2022
1	tegoprazanIBA 01/2022
1	Syndecan-2IBA 10/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	CateninsIBA 11/2019
1	AntralIBA 10/2016
1	FluoroquinolonesIBA 12/2015
1	Levofloxacin (Levaquin)FDA Link 12/2015
1	finafloxacinIBA 12/2015
1	VimentinIBA 05/2015
1	Proton Pump InhibitorsIBA 08/2014
1	Virulence Factors (Pathogenicity Factors)IBA 05/2014
1	Metformin (Glucophage)FDA LinkGeneric 03/2014
1	Biomarkers (Surrogate Marker)IBA 11/2013
1	Celecoxib (Celebrex)FDA Link 09/2013
1	ErbB Receptors (EGF Receptor)IBA 09/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2013
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 09/2013
1	LipocalinsIBA 04/2013
1	SiderophoresIBA 04/2013
1	Ethanol (Ethyl Alcohol)IBA 01/2013
1	deguelinIBA 11/2012
1	Biological ProductsIBA 07/2012

Therapy/Procedure

11	Therapeutics 01/2022 - 09/2003
2	Intraperitoneal Injections 03/2014 - 02/2008
1	Drug Therapy (Chemotherapy) 10/2017